Use of prophylactic growth factors and antimicrobials in elderly patients with cancer: a review of the Medicare database

Medicine & Life Sciences

• Medicare 100%
• Intercellular Signaling Peptides and Proteins 78%
• Elderly 65%
• Databases 58%
• Drug Therapy 57%
• Non-Hodgkin's Lymphoma 45%
• Febrile Neutropenia 40%
• Lung Neoplasms 38%
• Granulocyte Colony-Stimulating Factor 34%
• Neoplasms 31%
• Breast Neoplasms 30%
• Patient Care Bundles 25%
• Comorbidity 25%
• Anti-Bacterial Agents 21%
• Fee-for-Service Plans 20%
• Centers for Medicare and Medicaid Services (U.S.) 20%
• Insurance 16%
• Health Care Costs 14%
• Poisons 11%
• Age Groups 11%
• Cohort Studies 11%
• Retrospective Studies 10%
• Safety 9%